Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (21-30 of 477) with videos related to

Pageof 48
Sort By:
The Journal of Rheumatology|August 3, 2014
Rheumatoid arthritis: are current research-based guidelines clinically relevant?Suzanne Kafaja, Daniel E Furst
Arthritis Research & Therapy|June 6, 2019
Targeting inflammatory pathways in axial spondyloarthritisDaniel E Furst, James S Louie
Clinics in Geriatric Medicine|May 25, 2005
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientVeena K Ranganath, Daniel E Furst
Arthritis Research & Therapy|August 29, 2014
Safety and feasibility of umbilical cord mesenchymal stem cells in treatment-refractory systemic lupus erythematosus nephritis: time for a double-blind placebo-controlled trial to determine efficacyThasia G Woodworth, Daniel E Furst
Rheumatic Diseases Clinics of North America|July 27, 2015
Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic ApproachesElizabeth R Volkmann, Daniel E Furst
Expert Review of Clinical Immunology|July 11, 2017
Update of sarilumb to treat rheumatoid arthritis based on randomized clinical trials: a systematic reviewAly M Aly, Daniel E Furst
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Problems encountered during anti-tumour necrosis factor therapySheetal B Desai, Daniel E Furst
Current Opinion in Rheumatology|November 1, 2002
Stem cell therapy in sclerodermaYolanda Braun-Moscovici, Daniel E Furst
Annals of Translational Medicine|March 26, 2019
Timely renal transplantation for scleroderma end-stage kidney disease patients can improve outcomes and quality of lifeThasia G Woodworth, Daniel E Furst
The Journal of Rheumatology|December 5, 2002
Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprineErnest G Seidman, Daniel E Furst
Pageof 48

Showing results (21-30 of 477) with videos related to

Sort By:
Pageof 48
The Journal of Rheumatology|August 3, 2014
Rheumatoid arthritis: are current research-based guidelines clinically relevant?Suzanne Kafaja, Daniel E Furst
Arthritis Research & Therapy|June 6, 2019
Targeting inflammatory pathways in axial spondyloarthritisDaniel E Furst, James S Louie
Clinics in Geriatric Medicine|May 25, 2005
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patientVeena K Ranganath, Daniel E Furst
Arthritis Research & Therapy|August 29, 2014
Safety and feasibility of umbilical cord mesenchymal stem cells in treatment-refractory systemic lupus erythematosus nephritis: time for a double-blind placebo-controlled trial to determine efficacyThasia G Woodworth, Daniel E Furst
Rheumatic Diseases Clinics of North America|July 27, 2015
Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic ApproachesElizabeth R Volkmann, Daniel E Furst
Expert Review of Clinical Immunology|July 11, 2017
Update of sarilumb to treat rheumatoid arthritis based on randomized clinical trials: a systematic reviewAly M Aly, Daniel E Furst
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Problems encountered during anti-tumour necrosis factor therapySheetal B Desai, Daniel E Furst
Current Opinion in Rheumatology|November 1, 2002
Stem cell therapy in sclerodermaYolanda Braun-Moscovici, Daniel E Furst
Annals of Translational Medicine|March 26, 2019
Timely renal transplantation for scleroderma end-stage kidney disease patients can improve outcomes and quality of lifeThasia G Woodworth, Daniel E Furst
The Journal of Rheumatology|December 5, 2002
Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprineErnest G Seidman, Daniel E Furst
Pageof 48